(Q71611166)
Statements
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group (English)
Emons G
Ortmann O
Teichert HM
Fassl H
Löhrs U
Kullander S
Kauppila A
Ayalon D
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references